P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines
- 1 April 1992
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 65 (4) , 538-544
- https://doi.org/10.1038/bjc.1992.111
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Multidrug Resistance Associated With Altered Topoisomerase II Activity--Topoisomerases II as Targets for Rational Drug DesignJNCI Journal of the National Cancer Institute, 1990
- Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant CellsJNCI Journal of the National Cancer Institute, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry, 1988
- Mechanism of multidrug resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channelsInternational Journal of Cancer, 1988
- Reversal of Adriamycin Resistance by Verapamil in Human Ovarian CancerScience, 1984
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970